George H. WangPartner
George H. Wang is a partner in the Mergers and Acquisitions and Private Equity Practice Groups in the New York office of Haynes and Boone, LLP. He has extensive experience in mergers and acquisitions, securities offerings, strategic alliances, financings, fund and venture capital transactions, licensing matters and general commercial advice.
George represents domestic and foreign clients in a wide variety of industries, including energy, financial services, telecommunications, technology, consumer products, insurance, real estate and life sciences.
Areas of Practice
Mergers and Acquisitions
- Capital Markets and Securities
- Mergers and Acquisitions
- Venture Capital/Emerging Company
Mergers and Acquisitions:
Acquisition for $1.6 billion by Mexican pension fund, Afore XXI, of Afore Bancomer from Spain’s Banco Bilbao Vizcaya Argentaria creating Mexico’s largest pension fund; Numerous acquisitions for a European-based private equity firm to establish a multi-billion dollar platform company located in the United States with operations in North America, Europe, Asia and Latin America; Represent South Korean solar panel manufacturer in auction bid for $300 million greenfield solar farm in Southwestern United States; Various going private transactions for controlling shareholders and issuers; Various tender offers and tender offer-merger transactions for European and Asian-based acquirers; Sale of aviation assets by a European group to a Chinese investment fund; Acquisition for various European-based clients of target companies operating throughout Asia, South America, Europe and North America; Divestiture of an AMEX-listed distribution company to a publicly-traded German-based conglomerate; On behalf of a French publicly-traded company, merger with a Canadian-based NASDAQ-listed technology company; Various stock and asset acquisitions, divestitures and mergers.
Initial and secondary public offerings for issuers and underwriters.
Private Equity and Venture Capital:
Later stage venture investments in Chinese digital media and online payment processing ventures; Equity roll-over and similar transactions with various private equity firms; Formation of co-investment private equity, venture capital and hedge funds; First and later stage convertible preferred stock and bridge financings for venture funds and portfolio companies engaged in online procurement, telecommunications, medical devices and other businesses; A bridge financing for an angel investor investing in the combination of an Asian manufacturer of integrated cellular phones/personal data address book organizers, and a U.S.-based distributor of cellular products.
Technology and Life Sciences:
Later stage venture investment in an in vivo biomarker medical technology company; Acquisition for a French group of a U.S. medical reagents manufacturer; A cross-licensing transaction between a major European blood bank and a NASDAQ-traded biotechnology company; A supra-voting exchange offer and change of control transaction for a leading manufacturer of medical devices; A cross-licensing joint venture for U.K. and U.S. chip manufacturers for development of state of-the-art chipsets; Licensing agreements for a variety of technology-based companies.
Licensing agreements for a leading French fashion house for the domestic licensing of its globally known trademarks in the fashion and related industries; Revolving credit, term loan and letter of credit facilities on behalf of various corporate borrowers; Equity financing for a U.S. investor in a Chinese joint venture established to commercialize cosmetics products in the domestic Chinese market.
New York; U.S. Patent and Trademark Office
J.D., Cornell University Law School, 1978
M.S., Massachusetts Institute of Technology, 1975
B.S., Cornell University, 1973